280E tax compliance cannabis rules split down the middle in 2026. On April 23, the Department of Justice moved state-licensed medical cannabis into Schedule III, and just like that, Section 280E stopped applying to that slice of the business. Adult-use cannabis didn’t move. It’s still sitting on Schedule I, which means the same dispensary can now run two completely different federal tax profiles under one roof.
If your license only touches one market, this is a simpler story. If you’re like most of Collateral Base’s Illinois clients — holding both a medical dispensary license and an adult-use license, sharing a building, a POS system, and a budtender staff — this is the accounting problem of the year.
What You’ll Learn
- The New 280E Reality: One Schedule, Two Tax Worlds
- Why 280E Relief Doesn’t Apply Evenly to Mixed-License Operators
- 280E Tax Compliance Cannabis: 7 Critical Moves to Make Now
- A Worked Example: Splitting the Books at a Dual-License Dispensary
- The Legal Side Your Books Can’t Fix
- Frequently Asked Questions
The New 280E Reality: One Schedule, Two Tax Worlds
For most of the modern cannabis industry’s existence, 280E tax compliance was cannabis’s single biggest financial headache. Section 280E of the Internal Revenue Code denies ordinary business deductions — payroll, rent, marketing, insurance, professional fees — to any company “trafficking” in a Schedule I or Schedule II controlled substance. Cannabis businesses could deduct cost of goods sold and little else, which routinely pushed effective federal tax rates north of 60-70% even in a good year.
That changed, partially, on April 23, 2026. The DOJ’s final order placed FDA-approved cannabis products and cannabis handled under a qualifying state medical license into Schedule III. According to the U.S. Department of the Treasury, the shift carries “significant positive tax consequences” for medical operators, because 280E only reaches Schedule I and II substances — and qualifying medical cannabis activity no longer is one.
Adult-use cannabis was left exactly where it started. It remains Schedule I, and every dollar of recreational revenue is still subject to full 280E treatment. Meanwhile, the DEA’s administrative hearing on broader, adult-use rescheduling ran from June 29 through July 15, 2026, and has now closed. Chief Administrative Law Judge Derek Julius set an August 17 deadline for optional post-hearing briefs, after which he’ll issue a recommendation — with no announced timeline for the DEA Administrator’s final call, according to Marijuana Moment’s coverage of the hearing’s close.
Translation for operators: the medical side of 280E tax compliance for cannabis businesses is real and current. The adult-use side is still waiting, with no fixed date. Plan for both.
Why 280E Relief Doesn’t Apply Evenly to Mixed-License Operators
Here’s where it gets complicated for anyone running more than a single-license, single-market shop. Most multi-license operators — and nearly every Illinois dispensary, since the state’s original licensing structure paired medical and adult-use authority — share almost everything between the two lines of business.
Think the same four walls, the same inventory system, the same budtenders working the same shifts, the same marketing spend, the same management team.
If 280E relief only applies to the qualifying medical portion of revenue, then a mixed-license operator can no longer treat the business as one undifferentiated P&L for federal tax purposes. Shared costs — labor, rent, security, software, marketing — have to be allocated between the medical activity that now gets normal deductions and the adult-use activity that still doesn’t. Treasury has said it expects to issue further guidance on exactly how businesses with mixed activity should handle this, but the direction of travel is already clear enough to start preparing.
This is also where cost of goods sold discipline matters more than ever. COGS has always been the one deduction 280E couldn’t touch, and getting it right is the foundation of any 280E tax compliance cannabis strategy. If your inventory system can’t tell you which units of flower, vape, and edible moved through the medical register versus the adult-use register, you don’t have a tax allocation problem yet — you have an inventory problem, and it’s worth fixing before it becomes one. Our breakdown of dispensary inventory management covers the AI and POS-data techniques that make this kind of tracking possible without adding headcount.
For the mechanics of how 280E disallowance works in the first place — and why COGS has always been the safe harbor — see our foundational piece on the IRS 280E tax code and its impact on a cannabis financial model.
What Treasury Has Signaled About Mixed Activity
Treasury’s public statements indicate that upcoming guidance will address exactly this scenario — businesses with both qualifying and non-qualifying activity under the same roof. Until that guidance lands, the safest posture is to build the documentation now: clean separation of medical and adult-use revenue, a written allocation methodology for shared expenses, and records that would hold up if the IRS asks how a deduction was calculated after the fact. Operators who wait for final rules before organizing their books will be scrambling to reconstruct a year of transactions instead of defending a system they already built.
280E Tax Compliance Cannabis: 7 Critical Moves to Make Now
None of this requires a crystal ball. It requires discipline, and most of it can start this quarter.
- 1. Segregate medical and adult-use revenue in the chart of accounts. If your POS and general ledger can’t split sales by license type at the SKU and transaction level, that’s the first fix. Every downstream allocation depends on this being clean.
- 2. Write down your shared-expense allocation methodology. Labor, rent, security, marketing, and management costs that touch both license types need a documented, consistent allocation basis — square footage, revenue mix, labor hours, whatever fits your operation — applied the same way every month.
- 3. Revisit entity and holding company structure. Some operators are finding it cleaner to formally separate medical and adult-use operations into distinct entities under a holding company rather than allocate everything internally. Whether that makes sense depends on your state’s licensing rules and your existing structure — this is a case-by-case call with your advisors, not a blanket recommendation.
- 4. Model both scenarios for cash flow. Run your 2026 projections two ways: full 280E relief on qualifying medical activity, and continued exposure if guidance narrows the relief further than expected. Knowing your range before year-end tax planning beats finding out in April 2027.
- 5. Get ahead of DEA Schedule III registration questions. Reporting indicates medical cannabis businesses may need to register with the DEA to be considered Schedule III compliant, and industry attorneys have flagged concerns about how that registration process is worded. Loop in counsel before you file anything.
- 6. Watch the adult-use track, but don’t plan your books around a date. The DEA hearing closed July 15 with briefs due August 17 and no announced decision timeline after that. Keep adult-use activity on its current 280E treatment until there’s an actual rule to point to.
- 7. Revisit your valuation assumptions. Tax posture is a direct input into EBITDA add-backs and multiples. A license that’s now partially free of 280E is worth a different number than it was in March. See our guide to cannabis business valuation for how buyers and sellers are adjusting for this right now.
A Worked Example: Splitting the Books at a Dual-License Dispensary
Picture a single-location Illinois dispensary running both a medical and adult-use license out of one building — a common structure among Collateral Base clients, and one that just got more complex under SB 3222’s operator changes. Roughly 20% of its revenue comes from medical patients; the rest is adult-use. Here’s a simplified look at how shared costs might be allocated once medical activity qualifies for 280E relief and adult-use doesn’t:
| Cost Category | Allocation Basis | Medical (Deductible) | Adult-Use (Still 280E-Limited) |
|---|---|---|---|
| Rent & utilities | Square footage / revenue mix | ~20% | ~80% |
| Budtender payroll | Transaction count by register | ~18% | ~82% |
| Marketing spend | Campaign targeting (medical vs. adult-use promos) | Direct-traced where possible | Direct-traced where possible |
| Security & compliance software | Flat allocation (shared infrastructure) | ~20% | ~80% |
The exact percentages will never be identical to your business, and the allocation basis you choose has to be defensible and consistently applied — not just whatever produces the lowest tax bill this year. That’s the standard any operator should hold their own books to before an IRS reviewer does it for them.
The Legal Side Your Books Can’t Fix
280E tax compliance cannabis is an accounting problem with a legal dependency. Schedule III status is not full federal legalization, and it doesn’t resolve every open question about how state-licensed operators fit into a federal regulatory scheme built for pharmaceutical-grade Schedule III substances. There are real, unresolved litigation theories tied to the April order — from the scope of “qualifying” medical activity to how DEA registration requirements interact with state licensing. Our sister firm at Cannabis Industry Lawyer has mapped out the legal challenge theories every operator should plan for, and it’s worth a read alongside this piece — tax planning built on top of an unresolved legal question is planning you may have to redo. For a plain-language recap of exactly what happened at the DEA hearing and what comes next, Cannabis Legalization News broke down the hearing’s close the week it happened.
How Collateral Base Helps
280E tax compliance cannabis is exactly the kind of cross-disciplinary problem Collateral Base was built for: license structure, financial modeling, and operational accounting under one roof, working alongside your CPA and counsel rather than replacing them. If your dispensary is sitting on both a medical and adult-use license and your books still treat it as one business, that’s a conversation worth having before your next quarterly filing, not after.
Talk to a cannabis business consultant about your 2026 tax posture. Book a $200 expert consultation — it’s credited toward any engagement, and 30 minutes is usually enough to tell you whether your current books can support the deductions you’re about to claim. You can also see the full scope of our cannabis consulting services for licensing and operations support beyond tax.
Frequently Asked Questions
Does 280E still apply to adult-use cannabis in 2026?
Yes. The April 23, 2026 DOJ order moved FDA-approved cannabis products and state-licensed medical cannabis activity to Schedule III, which removes 280E’s deduction disallowance for that qualifying activity. Adult-use, or recreational, cannabis remains on Schedule I and is still fully subject to Section 280E as of this writing.
What exactly did the DOJ’s April 2026 rescheduling order do?
It reclassified FDA-approved marijuana drug products and cannabis handled under a qualifying state medical marijuana license from Schedule I to Schedule III of the Controlled Substances Act, effective immediately. It did not reschedule cannabis broadly and does not apply to adult-use or unlicensed activity.
When will the DEA decide on rescheduling adult-use cannabis?
The DEA’s administrative hearing on broader rescheduling ran June 29 through July 15, 2026. Post-hearing briefs are due August 17, after which the administrative law judge will issue a recommendation to the DEA Administrator. No timeline has been announced for either the recommendation or the Administrator’s final decision.
How should a dispensary with both a medical and adult-use license separate its books?
For 280E tax compliance, cannabis operators with mixed licenses should start by segregating medical and adult-use revenue at the point-of-sale and transaction level, then build a documented, consistent allocation methodology for shared costs like rent, payroll, security, and marketing. Treasury has indicated further guidance is coming for mixed-activity businesses, so the priority now is clean, defensible records rather than aggressive assumptions.
Is this article tax or legal advice?
No. This article is educational and reflects federal rescheduling and tax developments as of July 2026, which remain subject to further agency guidance. Consult your CPA and attorney before making tax filing or entity structure decisions based on your specific facts and state.
Next Steps
280E tax compliance cannabis just became a two-track problem: real, current relief for qualifying medical activity, and an unresolved waiting game for adult-use. The operators who come out ahead won’t be the ones who guess right about timing — they’ll be the ones whose books were already clean enough to claim the deduction the moment it applied.
Disclaimer: This article discusses federal cannabis rescheduling and Section 280E as of July 2026. Rules are evolving, additional Treasury and DEA guidance is expected, and state tax treatment varies by jurisdiction. This is not legal or tax advice — consult a qualified attorney and CPA before making decisions specific to your business.
